Risk factors for deep vein thrombosis even using low-molecular-weight heparin after total knee arthroplasty

被引:18
|
作者
Lee, Joon Kyu [1 ,2 ]
Lee, Kee Byoung [3 ]
Kim, Joong Il [4 ]
Park, Gun Tae [5 ]
Cho, Young Chang [1 ]
机构
[1] Konkuk Univ, Med Ctr, Dept Orthopaed Surg, 120-1 Neungdong Ro, Seoul 05030, South Korea
[2] Konkuk Univ, Sch Med, Res Inst Med Sci, 120-1 Neungdong Ro, Seoul 05030, South Korea
[3] Cheongju St Marys Hosp, Dept Orthopaed Surg, 173-19 Jusung Ro, Cheongju 28323, Chungcheongbuk, South Korea
[4] Hallym Univ, Kangnam Sacred Heart Hosp, Dept Orthopaed Surg, 1 Singil Ro, Seoul 07741, South Korea
[5] Hallym Univ, Dept Orthopaed Surg, Sacred Heart Hosp, 22 Gwanpyeong Ro, Anyang Si 14068, Gyeonggi Do, South Korea
关键词
Deep vein thrombosis; Total knee arthroplasty; Anticoagulant agent; Low-molecular-weight-heparin; Risk factor; MAJOR ORTHOPEDIC-SURGERY; TOTAL HIP-ARTHROPLASTY; VENOUS THROMBOEMBOLISM; PULMONARY-EMBOLISM; GENERAL-ANESTHESIA; ASIAN PATIENTS; THROMBOPROPHYLAXIS; FONDAPARINUX; REPLACEMENT; ENOXAPARIN;
D O I
10.1186/s43019-021-00109-z
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background With an increase in deep vein thrombosis (DVT) following total knee arthroplasty (TKA) in the Asian population, most surgeons today use a form of prophylactic anticoagulant agents in patients after TKA. Nevertheless, DVT occasionally develops even in these patients with prophylaxis. The purpose of this study was to identify the risk factors for DVT after TKA in cases of postoperative low-molecular-weight heparin (LMWH) use. Methods We designed a retrospective study with 103 patients who underwent primary TKA. From the second postoperative day, 60 mg of LMWH was subcutaneously injected into the patients daily. On the seventh postoperative day, patients had computed tomography angiography to check whether they had DVT. Regarding risk factors, we investigated patients' gender, age, surgical site (unilateral/bilateral), body mass index, method of anesthesia, preoperative hypertension, diabetes, hypercholesterolemia status, and prothrombin time/international normalized ratio from electronic medical records. We analyzed the statistical significance of these risk factors. Results Statistically significant factors in the single-variable analysis were surgical site (unilateral/bilateral), body mass index, preoperative hypertension status, and anesthesia method. Multiple logistic regression analysis with these factors revealed that the surgical site (unilateral/bilateral, p = 0.024) and anesthesia method (p = 0.039) were significant factors for the occurrence of postoperative DVT after TKA. Conclusions Patients undergoing simultaneous bilateral TKAs and patients undergoing TKA with general anesthesia need more attention regarding DVT even with chemoprophylaxis using LMWH after TKA.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Prevention of Deep Vein Thrombosis by Panax Notoginseng Saponins Combined with Low-Molecular-Weight Heparin in Surgical Patients
    Wang Chun-mei
    Guo Xiang-feng
    Liu Li-min
    Huang Ying
    Meng Liang
    Song Li-po
    Wu Ying-feng
    Ning Ye-chan
    Reilly, Kathleen H.
    Wang Hai-bo
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2022, 28 (09) : 771 - 778
  • [22] Foot Pump Versus Low-Molecular-Weight Heparin for Preventing Deep Vein Thrombosis Following Surgery for Hip and Knee Replacement
    Lin, Feng-Fei
    Chen, Bin
    Lin, Chao-Hui
    Zheng, Ke
    INTERNATIONAL SURGERY, 2021, 105 (1-3) : 389 - 396
  • [23] LOW-MOLECULAR-WEIGHT HEPARIN WITHOUT ORAL ANTICOAGULANTS FOR THE TREATMENT OF DEEP VEIN THROMBOSIS
    Alonso Martinez, J. L.
    Abinzano Guillen, M. L.
    Urbieta Echezarreta, M. A.
    Annicherico Sanchez, F. J.
    Fernandez Ladron, V.
    Garcia Sanchotena, J. L.
    ANALES DE MEDICINA INTERNA, 2008, 25 (01) : 4 - 8
  • [24] Plasma D-dimer is not useful in the prediction of deep vein thrombosis after total knee arthroplasty in patients using rivaroxaban for thromboprophylaxis
    Wu, Cheng-Ta
    Chen, Bradley
    Wang, Jun-Wen
    Yen, Shih-Hsiang
    Huang, Chung-Cheng
    JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2018, 13
  • [25] Incidence and Risk Factors for Post-Thrombotic Syndrome in Patients With Deep Vein Thrombosis Following Total Knee and Hip Arthroplasty
    Zhang, Zhe
    Song, Kai
    Yao, Yao
    Jiang, Tao
    Pan, Pin
    Jiang, Qing
    JOURNAL OF ARTHROPLASTY, 2019, 34 (03): : 560 - 563
  • [26] Dosage, anticoagulant, and antithrombotic effects of heparin and low-molecular-weight heparin in the treatment of deep vein thrombosis
    Harenberg, J
    Stehle, G
    Blauth, M
    Huck, K
    Mall, K
    Heene, DL
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1997, 23 (01): : 83 - 90
  • [27] Low-molecular-weight heparins versus unfractionated heparin in the treatment of deep vein thrombosis and pulmonary embolism
    Merli, GJ
    AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 2000, 79 (05) : S9 - S16
  • [28] The effects of location and low-molecular-weight heparin administration on deep vein thrombosis outcomes in trauma patients
    Lee, Tim H.
    Alonzo, Brock J.
    Differding, Jerome
    Underwood, Samantha J.
    Hamilton, Greg
    Kremenevskiy, Igor
    McNamara, Steve
    Schreiber, Martin A.
    JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2013, 74 (02): : 476 - 481
  • [29] Effect of oral factor Xa inhibitor and low-molecular-weight heparin on surgical complications following total hip arthroplasty
    Kim, Sang-Min
    Moon, Young-Wan
    Lim, Seung-Jae
    Kim, Dong-Wook
    Park, Youn-Soo
    THROMBOSIS AND HAEMOSTASIS, 2016, 115 (03) : 600 - 607
  • [30] A nested case-control study on the risk factors of deep vein thrombosis for Chinese after total joint arthroplasty
    Xu, Hong
    Zhang, Shaoyun
    Xie, Jinwei
    Lei, Yiting
    Cao, Guorui
    Chen, Guo
    Pei, Fuxing
    JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2019, 14 (1)